Investigating how chemical exposures affect breast cancer disparities in African American women
Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities
This study is looking at how certain chemicals in our environment might affect breast cancer, especially for African American women who often face more severe forms of the disease, to find better ways to prevent and treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10975376 on NIH RePORTER |
What this research studies
This research aims to understand the impact of chemical exposures on breast cancer disparities, particularly focusing on African American women who are disproportionately affected by aggressive breast cancer types. The study will analyze chemical biomarkers and their relationship to breast cancer biology and mortality rates. By examining how these environmental factors contribute to the development of aggressive breast cancers, the research seeks to identify new strategies for prevention and treatment tailored to affected populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American women, particularly those at risk for or diagnosed with aggressive breast cancer types.
Not a fit: Patients who do not identify as African American or those with non-aggressive breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and targeted treatments for aggressive breast cancer in African American women.
How similar studies have performed: Previous research has shown success in identifying environmental factors contributing to health disparities, making this approach both relevant and promising.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Colacino, Justin Adam — University of Michigan at Ann Arbor
- Study coordinator: Colacino, Justin Adam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.